Andrejs Millers

Medicine & Life Sciences

1. Stroke 100%
2. Multiple Sclerosis 66%
3. Latvia 59%
4. Carotid Stenosis 35%
5. Thrombectomy 33%
6. Human Herpesvirus 6 28%
7. University Hospitals 25%
8. Optic Neuritis 24%
9. Ships 20%
10. Chronic Progressive Multiple Sclerosis 20%
11. siponimod 20%
12. Visual Evoked Potentials 20%
13. Middle Cerebral Artery Infarction 19%
14. Secondary Prevention 18%
15. ocrelizumab 18%
16. teriflunomide 17%
17. ofatumumab 17%
18. Anticoagulants 17%
19. xylometazoline 16%
20. Human Herpesvirus 7 16%
21. Patient Health Questionnaire 16%
22. Prospective Studies 16%
23. Interferon beta-1a 15%
24. levodopa drug combination carbidopa 15%
25. Survivors 15%
26. Decompressive Craniectomy 15%
27. Optical Coherence Tomography 14%
28. National Institutes of Health (U.S.) 14%
29. Quality of Life 14%
30. Primary Prevention 13%
31. Carotid Endarterectomy 13%
32. Chlamydophila pneumoniae 13%
33. Hyperhomocysteinemia 13%
34. Polysorbates 12%
35. Mortality 12%
36. Conservative Treatment 12%
37. Placebos 12%
38. Therapeutics 11%
39. Mental Status and Dementia Tests 11%
40. Cytomegalovirus Infections 11%
41. Middle Cerebral Artery 11%
42. Cerebral Infarction 11%
43. Pandemics 11%
44. Reperfusion 10%
45. Optic Nerve 10%
46. Vasculitis 10%
47. Glasgow Coma Scale 10%
48. Neurologic Manifestations 10%
49. Hematoma 9%
50. Population 9%